New price regime: Govt extends deadline to drug makers by 30 days

Firms are mandated to change prices of medicines within 45 days of NPPA's notification

Sushmi Dey New Delhi
Last Updated : Aug 08 2013 | 9:58 AM IST
Unmindful of the Supreme Court’s criticism against the Centre’s “dilly-dallying” on fixing the prices of essential medicines, the government has accepted the industry’s demand to extend the deadline for implementing the new prices by a month.

In a meeting with industry representatives in Mumbai on Wednesday, the government decided to allow companies an additional 30 days’ time from July 29, when the first deadline ended, to liquidate existing stocks of essential medicines from the market and replace them with newly-priced medicines, official sources said. “However, the extension will be valid only for 151 medicines, which were part of the first notification by NPPA (National Pharmaceutical Pricing Authority),” the official clarified. For the rest of the drugs, firms will have to stick to the 45-day time period to withdraw existing stocks and replace them with newly-priced medicines.

ALSO READ: Drug pricing: Govt gets SC rap for 'dilly-dallying'

The meeting, chaired by Department of Pharma Secretary D S Kalha and NPPA Chairman C P Singh, was aimed at addressing the industry’s concerns on the new Drug Price Control Order (DPCO), 2013, notified by the government in May.

The move comes in the wake of several major drug makers approaching high courts challenging various provisions of the DPCO, which intends to regulate prices of 348 essential medicines or their 652 packs in line with the new drug pricing policy.

According to the law, companies are mandated to change prices of medicines within 45 days of NPPA's notification of new prices. However, the industry argued the time is short for replacing the stocks as medicines are supplied even to remote areas.

ALSO READ: Drug price cuts not applied

“The reverse logistics of getting the old product packs back from the retailers or wholesalers to our warehouses, and replacing the same with products printed with revised prices is very time-consuming,” a Sanofi spokesperson told Business Standard a few days ago.

Beside the extension, the government has also allowed an excise duty exemption on repackaging or re-labelling of such products, whose prices have to be revised.

Since the finance ministry’s notification allowing the exemption was issued only on July 29, the 30-day extension will now help the industry to take its benefit and implement the new prices, the official source pointed out.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 08 2013 | 12:46 AM IST

Next Story